122 related articles for article (PubMed ID: 2158387)
1. Attenuation of febrile seizures in epileptic chicks by N-methyl-D-aspartate receptor antagonists.
Pedder SC; Wilcox RI; Tuchek JM; Johnson DD; Crawford RD
Can J Physiol Pharmacol; 1990 Jan; 68(1):84-8. PubMed ID: 2158387
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
Nevins ME; Arnolde SM
Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
[TBL] [Abstract][Full Text] [Related]
3. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
4. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
Kurumaji A; Nehls DG; Park CK; McCulloch J
Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
[TBL] [Abstract][Full Text] [Related]
5. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
Stasheff SF; Anderson WW; Clark S; Wilson WA
Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
[TBL] [Abstract][Full Text] [Related]
6. Effects of antagonists on N-methyl-D-aspartate response in acutely isolated nucleus tractus solitarii neurons of the rat.
Nakagawa T; Shirasaki T; Tateishi N; Murase K; Akaike N
Neurosci Lett; 1990 May; 113(2):169-74. PubMed ID: 1974040
[TBL] [Abstract][Full Text] [Related]
7. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
8. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
9. Labeling of NMDA receptor channels by [3H]MK-801 in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K
Brain Res; 1989 Oct; 499(2):305-14. PubMed ID: 2572302
[TBL] [Abstract][Full Text] [Related]
10. The relationship between anticonvulsant activity and receptor affinity of N-methyl-D-aspartate antagonists in epileptic fowl.
Pedder SC; Wilcox R; Tuchek JM; Johnson DD; Crawford RD
Neuropharmacology; 1989 Jul; 28(7):753-6. PubMed ID: 2548114
[TBL] [Abstract][Full Text] [Related]
11. Homocysteic acid as a putative excitatory amino acid neurotransmitter: I. Postsynaptic characteristics at N-methyl-D-aspartate-type receptors on striatal cholinergic interneurons.
Lehmann J; Tsai C; Wood PL
J Neurochem; 1988 Dec; 51(6):1765-70. PubMed ID: 2846784
[TBL] [Abstract][Full Text] [Related]
12. Selective N-methyl-D-aspartate (NMDA) antagonists increase gastric motility in the rat.
Shinozaki H; Gotoh Y; Ishida M
Neurosci Lett; 1990 May; 113(1):56-61. PubMed ID: 1973272
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.
Nehls DG; Kurumaji A; Park CK; McCulloch J
Neurosci Lett; 1988 Aug; 91(2):204-10. PubMed ID: 2847086
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant effects of antagonists of the N-methyl-D-aspartate receptor complex in a genetic model of epilepsy: the quaking mouse.
Mitrovic N; Besson MJ; Maurin Y
Eur J Pharmacol; 1990 Feb; 176(3):357-61. PubMed ID: 2158455
[TBL] [Abstract][Full Text] [Related]
15. Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning.
Chiamulera C; Costa S; Reggiani A
Psychopharmacology (Berl); 1990; 102(4):551-2. PubMed ID: 1982904
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of dopamine release from cultured rat mesencephalic cells by naturally occurring excitatory amino acids: involvement of both N-methyl-D-aspartate (NMDA) and non-NMDA receptor subtypes.
Mount H; Quirion R; Chaudieu I; Boksa P
J Neurochem; 1990 Jul; 55(1):268-75. PubMed ID: 1972390
[TBL] [Abstract][Full Text] [Related]
17. Kynurenate and 2-amino-5-phosphonovalerate interact with multiple binding sites of the N-methyl-D-aspartate-sensitive glutamate receptor domain.
Danysz W; Fadda E; Wroblewski JT; Costa E
Neurosci Lett; 1989 Jan; 96(3):340-4. PubMed ID: 2566140
[TBL] [Abstract][Full Text] [Related]
18. Protection by NMDA antagonists against selective cell loss following transient ischaemia.
Swan JH; Meldrum BS
J Cereb Blood Flow Metab; 1990 May; 10(3):343-51. PubMed ID: 2158499
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
Marrannes R; Willems R; De Prins E; Wauquier A
Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
[TBL] [Abstract][Full Text] [Related]
20. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
